Harrow, Inc. Interest Expense
Harrow, Inc. (HROW) reported Interest Expense of $5.42 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-13.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-05-13
- Harrow, Inc. interest expense for the quarter ending 2024-03-31 was $5.42M, a 14.07% increase year-over-year.
- Harrow, Inc. interest expense for the quarter ending 2023-12-31 was $5.12M, a 175.78% increase year-over-year.
- Harrow, Inc. interest expense for the quarter ending 2023-09-30 was $5.75M, a 219.39% increase year-over-year.
- Harrow, Inc. interest expense for the quarter ending 2023-06-30 was $5.70M, a 217.95% increase year-over-year.
- Harrow, Inc. interest expense for fiscal 2023 was $21.32M, a 194.37% increase from fiscal 2022.
- Harrow, Inc. interest expense for fiscal 2022 was $7.24M, a 33.26% increase from fiscal 2021.
- Harrow, Inc. interest expense for fiscal 2021 was $5.44M.
- Harrow, Inc. interest expense for fiscal 2014 was $3.80K.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month | Interest Expense 155 month | Interest Expense 158 month | Interest Expense 161 month | Interest Expense 164 month | Interest Expense 167 month | Interest Expense 170 month | Interest Expense 173 month | Interest Expense 176 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | $5.42M 10-Q · filed 2024-05-13 | $10.54M derived: sum of 2 quarters · filed 2024-05-13 | $16.29M derived: sum of 3 quarters · filed 2024-05-13 | $21.99M derived: sum of 4 quarters · filed 2024-05-13 | ||||||||
| 2023-12-31 | $5.12M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $10.87M derived: sum of 2 quarters · filed 2024-03-19 | $16.58M derived: sum of 3 quarters · filed 2024-03-19 | $21.32M 10-K · filed 2024-03-19 | ||||||||
| 2023-09-30 | $5.75M 10-Q · filed 2023-11-13 | $11.45M derived: sum of 2 quarters · filed 2023-11-13 | $16.20M 10-Q · filed 2023-11-13 | $18.06M derived: sum of 4 quarters · filed 2024-05-13 | ||||||||
| 2023-06-30 | $5.70M 10-Q · filed 2023-08-09 | $10.45M 10-Q · filed 2023-08-09 | $12.31M derived: sum of 3 quarters · filed 2024-05-13 | $14.11M derived: sum of 4 quarters · filed 2024-05-13 | ||||||||
| 2023-03-31 | $4.75M 10-Q · filed 2024-05-13 | $6.61M derived: sum of 2 quarters · filed 2024-05-13 | $8.40M derived: sum of 3 quarters · filed 2024-05-13 | $10.20M derived: sum of 4 quarters · filed 2024-05-13 | ||||||||
| 2022-12-31 | $1.86M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $3.66M derived: sum of 2 quarters · filed 2024-03-19 | $5.45M derived: sum of 3 quarters · filed 2024-03-19 | $7.24M 10-K · filed 2024-03-19 | ||||||||
| 2022-09-30 | $1.80M 10-Q · filed 2023-11-13 | $3.59M derived: sum of 2 quarters · filed 2023-11-13 | $5.39M 10-Q · filed 2023-11-13 | $7.31M derived: sum of 4 quarters · filed 2023-11-13 | ||||||||
| 2022-06-30 | $1.79M 10-Q · filed 2023-08-09 | $3.59M 10-Q · filed 2023-08-09 | $5.51M derived: sum of 3 quarters · filed 2023-08-09 | $7.20M derived: sum of 4 quarters · filed 2023-08-09 | ||||||||
| 2022-03-31 | $1.79M 10-Q · filed 2023-05-11 | $3.72M derived: sum of 2 quarters · filed 2023-05-11 | $5.40M derived: sum of 3 quarters · filed 2023-05-11 | $6.71M derived: sum of 4 quarters · filed 2023-05-11 | ||||||||
| 2021-12-31 | $1.92M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $3.61M derived: sum of 2 quarters · filed 2023-03-23 | $4.92M derived: sum of 3 quarters · filed 2023-03-23 | $5.44M 10-K · filed 2023-03-23 | ||||||||
| 2021-09-30 | $1.69M 10-Q · filed 2022-11-14 | $3.00M derived: sum of 2 quarters · filed 2022-11-14 | $3.51M 10-Q · filed 2022-11-14 | |||||||||
| 2021-06-30 | $1.31M 10-Q · filed 2022-08-09 | $1.83M 10-Q · filed 2022-08-09 | ||||||||||
| 2021-03-31 | $513.00K 10-Q · filed 2022-05-05 | |||||||||||
| 2020-09-30 | $498.00K 10-Q · filed 2021-11-09 | $1.56M 10-Q · filed 2021-11-09 | ||||||||||
| 2014-12-31 | $1.24K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $2.23K derived: sum of 2 quarters · filed 2015-03-12 | $3.80K 10-K · filed 2015-03-12 | |||||||||
| 2014-09-30 | $993.00 10-Q · filed 2014-11-12 | $2.56K 10-Q · filed 2014-11-12 | ||||||||||
| 2013-06-30 | $1.73M 10-Q · filed 2013-08-14 | |||||||||||
| 2013-03-31 | $0.00 10-Q · filed 2013-05-08 | $0.00 derived: sum of 2 quarters · filed 2013-05-08 | $0.00 derived: sum of 3 quarters · filed 2013-05-08 | $3.58K derived: sum of 4 quarters · filed 2013-08-14 | $1.73M 10-Q · filed 2013-05-08 | |||||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $0.00 derived: sum of 2 quarters · filed 2013-03-18 | $3.58K derived: sum of 3 quarters · filed 2013-08-14 | $24.66K 10-K · filed 2013-03-18 | $1.73M 10-K · filed 2013-03-18 | |||||||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $3.58K derived: sum of 2 quarters · filed 2013-08-14 | $24.66K 10-Q · filed 2012-11-14 | $43.56K derived: sum of 4 quarters · filed 2013-08-14 | $1.73M 10-Q · filed 2012-11-14 | |||||||
| 2012-06-30 | $3.58K 10-Q · filed 2013-08-14 | $24.66K 10-Q · filed 2013-08-14 | $43.56K derived: sum of 3 quarters · filed 2013-08-14 | $62.47K derived: sum of 4 quarters · filed 2013-08-14 | $1.73M 10-Q · filed 2012-08-14 | |||||||
| 2012-03-31 | $21.08K 10-Q · filed 2013-05-08 | $39.99K derived: sum of 2 quarters · filed 2013-05-08 | $58.89K derived: sum of 3 quarters · filed 2013-05-08 | $77.59K derived: sum of 4 quarters · filed 2013-05-08 | $1.73M 10-Q · filed 2012-05-10 | |||||||
| 2011-12-31 | $18.91K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $37.81K derived: sum of 2 quarters · filed 2013-03-18 | $56.51K derived: sum of 3 quarters · filed 2013-03-18 | $75.00K 10-K · filed 2013-03-18 | $1.71M 10-K · filed 2012-02-23 | |||||||
| 2011-09-30 | $18.90K 10-Q · filed 2012-11-14 | $37.60K derived: sum of 2 quarters · filed 2012-11-14 | $56.09K 10-Q · filed 2012-11-14 | $75.00K derived: sum of 4 quarters · filed 2012-11-14 | $1.69M 10-Q · filed 2012-02-23 | |||||||
| 2011-06-30 | $18.70K 10-Q · filed 2012-08-14 | $37.19K 10-Q · filed 2012-08-14 | $56.09K derived: sum of 3 quarters · filed 2012-08-14 | $75.00K derived: sum of 4 quarters · filed 2012-08-14 | $1.67M 10-Q · filed 2012-02-23 | |||||||
| 2011-03-31 | $18.49K 10-Q · filed 2012-05-10 | $37.40K derived: sum of 2 quarters · filed 2012-05-10 | $56.30K derived: sum of 3 quarters · filed 2012-05-10 | $73.97K derived: sum of 4 quarters · filed 2012-05-10 | ||||||||
| 2010-12-31 | $18.90K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-23 | $37.81K derived: sum of 2 quarters · filed 2012-02-23 | $55.48K derived: sum of 3 quarters · filed 2012-02-23 | $55.48K 10-K · filed 2012-02-23 | ||||||||
| 2010-09-30 | $18.90K 10-Q · filed 2012-02-23 | $36.58K derived: sum of 2 quarters · filed 2012-02-23 | $36.58K 10-Q · filed 2012-02-23 | |||||||||
| 2010-06-30 | $17.67K 10-Q · filed 2012-02-23 | $17.67K 10-Q · filed 2012-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |